Immunohistochemical and mutation analyses demonstrate that procollagen VII is processed to collagen VII through removal of the NC-2 domain.
Open Access
- 15 October 1995
- journal article
- Published by Rockefeller University Press in The Journal of cell biology
- Vol. 131 (2), 551-559
- https://doi.org/10.1083/jcb.131.2.551
Abstract
Collagen VII is the major structural constituent of anchoring fibrils in the skin. It is synthesized as a procollagen that is larger than the collagen deposited in the tissue. In this study, we investigated the conversion of procollagen VII to collagen VII in human skin and in cutaneous cells in vitro and identified the propeptide using domain-specific antibodies. For this purpose, two bacterial fusion proteins containing unique sequences of the carboxy-terminal globular NC-2 domain of procollagen VII were prepared, and polyclonal antibodies raised against them. Immunoblotting showed that the anti-NC2 antibodies reacted with procollagen VII isolated from cultured keratinocytes, but not with collagen VII extracted from the skin. Immunohistochemical experiments with the NC-2 antibodies revealed a strong reaction in cultured keratinocytes, but the basement membrane zone of normal skin remained negative. The staining could not be rendered positive by chemical or enzymatic unmasking of potential hidden epitopes in the skin, indicating that most of the NC-2 domain is absent from normal skin. In contrast, a positive staining with NC-2 antibodies was observed in the skin of a patient with NC-2 antibodies was observed in the skin of a patient with dystrophic epidermolysis bullosa, who carried a 14-bp deletion at one of the intro-exon junctions of the collagen VII gene. This aberration led to an in-frame skipping of exon 115 from the mRNA and eliminated 29 amino acids from the NC-2 domain which include the putative cleavage site for the physiological processing enzyme, procollagen C-proteinase. The results indicate that in normal human skin, the removal of the NC-2 domain from procollagen VII precedes its deposition at the dermal-epidermal junction. Furthermore, they suggest that an aberration in the procollagen VII cleavage interferes with the normal fibrillogenesis of the anchoring fibrils.Keywords
This publication has 23 references indexed in Scilit:
- Truncated Profibrillin of a Marfan Patient is of Apparent Similar Size as Fibrillin: Intracellular Retention Leads to over-N-glycosylationJournal of Molecular Biology, 1995
- Molecular Basis of the Dystrophic and Junctional Forms of Epidermolysis Bullosa: Mutations in the Type VII Collagen and Kalinin (Laminin 5) Genes.Journal of Investigative Dermatology, 1994
- Recombinant expression and properties of the Kunitz‐type protease‐inhibitor module from human type VI collagen α3(VI) chainJBIC Journal of Biological Inorganic Chemistry, 1994
- Structural Organization of the Human Type VII Collagen Gene (COL7A1), Composed of More Exons Than Any Previously Characterized GeneGenomics, 1994
- Type VII Collagen, Anchoring Fibrils, and Epidermolysis BullosaJournal of Investigative Dermatology, 1993
- A missense mutation in type VII collagen in two affected siblings with recessive dystrophic epidermolysis bullosaNature Genetics, 1993
- The carboxyl-terminal half of type VII collagen, including the non-collagenous NC-2 domain and intron/exon organization of the corresponding region of the COL7A1 geneHuman Molecular Genetics, 1993
- Transforming growth factor-beta stimulates collagen VII expression by cutaneous cells in vitro.The Journal of cell biology, 1992
- Epithelial origin of cutaneous anchoring fibrils.The Journal of cell biology, 1990
- Type I procollagen C‐proteinase from mouse fibroblastsJBIC Journal of Biological Inorganic Chemistry, 1989